Cargando…

Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker

Cyclin-dependent kinase 1 (CDK1) plays an important role in cancer development, progression, and the overall process of tumorigenesis. However, no pan-cancer analysis has been reported for CDK1, and the predictive role of CDK1 in immune checkpoint inhibitors (ICIs) therapy response remains unexplore...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yaqi, Liu, Qin, Guo, Xiyuan, Yuan, Qing, Nian, Siji, Kang, Pengyuan, Xu, Zixi, Li, Lin, Ye, Yingchun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452984/ https://www.ncbi.nlm.nih.gov/pubmed/36090896 http://dx.doi.org/10.1155/2022/8115474

Ejemplares similares

Pan-cancer analysis and experimental validation identify ndc1 as a potential immunological, prognostic and therapeutic biomarker in pancreatic cancer
por: Shen, Qian, et al.
Publicado: (2023)

Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker
por: Cheng, Xin, et al.
Publicado: (2021)

Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker
por: Xie, Pan, et al.
Publicado: (2022)

Systematic pan‐cancer analysis identifies RBM39 as an immunological and prognostic biomarker
por: Zhang, Rui, et al.
Publicado: (2022)

Systematic pan-cancer analysis identifies cGAS as an immunological and prognostic biomarker
por: Chen, Peng, et al.
Publicado: (2023)

A pan-cancer analysis identifies SOAT1 as an immunological and prognostic biomarker
por: HUANG, YANGQING, et al.
Publicado: (2023)

Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
por: Xu, Yingting, et al.
Publicado: (2023)

Integrative analysis identifies AKAP8L as an immunological and prognostic biomarker of pan-cancer
por: Zhou, Libo, et al.
Publicado: (2023)

Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role
por: Zhu, Hua, et al.
Publicado: (2021)

Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker
por: Liu, Kejun, et al.
Publicado: (2022)

Systematic pan-cancer landscape identifies CARM1 as a potential prognostic and immunological biomarker
por: Qiu, Yingqi, et al.
Publicado: (2022)

Systematic pan-cancer analysis identifies SLC35C1 as an immunological and prognostic biomarker
por: Xie, Mingchen, et al.
Publicado: (2023)

Systematic pan-cancer analysis identifies cuproptosis-related gene DLAT as an immunological and prognostic biomarker
por: Xu, Lidong, et al.
Publicado: (2023)

Title of article: Mucosal-associated invariant T cells in lung diseases
por: Wen, Xue, et al.
Publicado: (2021)

The value of WNT5A as prognostic and immunological biomarker in pan-cancer
por: Feng, Yingtong, et al.
Publicado: (2022)

Systematic analysis identifies XRCC4 as a potential immunological and prognostic biomarker associated with pan-cancer
por: Yu, Yang, et al.
Publicado: (2023)

Pan-cancer analysis identifies LIFR as a prognostic and immunological biomarker for uterine corpus endometrial carcinoma
por: Zhang, Fang, et al.
Publicado: (2023)

GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer
por: Chen, Guoming, et al.
Publicado: (2022)

Fully human recombinant antibodies against EphA2 from a multi-tumor patient immune library suitable for tumor-targeted therapy
por: Yang, Yaqi, et al.
Publicado: (2021)

MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
por: Chen, Dengwang, et al.
Publicado: (2023)

Pan-Cancer Analysis of B4GALNT1 as a Potential Prognostic and Immunological Biomarker
por: Yi, Hang, et al.
Publicado: (2022)

A pan-cancer analysis of thioredoxin-interacting protein as an immunological and prognostic biomarker
por: Guo, Xuxue, et al.
Publicado: (2022)

Pan-Cancer Analysis of FURIN as a Potential Prognostic and Immunological Biomarker
por: Zhou, Bolun, et al.
Publicado: (2021)

Pan-cancer analyses reveal IGSF10 as an immunological and prognostic biomarker
por: Zhou, Yongxia, et al.
Publicado: (2023)

Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker
por: Niu, Hongjuan, et al.
Publicado: (2022)

Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarker
por: He, Zhibo, et al.
Publicado: (2023)

Immunological role and prognostic value of SPARCL1 in pan-cancer analysis
por: He, Kangwei, et al.
Publicado: (2022)

Systematic Pan-Cancer Analysis and Experimental Verification Identify FOXA1 as an Immunological and Prognostic Biomarker in Epithelial Ovarian Cancer
por: Wang, Kai, et al.
Publicado: (2022)

Systematic pan-cancer analysis identifies gasdermin B as an immunological and prognostic biomarker for kidney renal clear cell carcinoma
por: Liu, Xuehe, et al.
Publicado: (2023)

Exploring the immunological role and prognostic potential of PPM1M in pan-cancer
por: Zeng, Rongruo, et al.
Publicado: (2023)

A Pan-Cancer Analysis of Prognostic and Immunological Roles for Cell Death Genes
por: Hong, Ye, et al.
Publicado: (2023)

Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker
por: Liu, Weiwei, et al.
Publicado: (2022)

HHLA2 Used as a Potential Prognostic and Immunological Biomarker and Correlated with Tumor Microenvironment in Pan-Cancer
por: Yang, Zeng, et al.
Publicado: (2022)

PPP1R14B Is a Prognostic and Immunological Biomarker in Pan-Cancer
por: Deng, Mingxia, et al.
Publicado: (2021)

PHF5A is a potential diagnostic, prognostic, and immunological biomarker in pan-cancer
por: Ding, Na, et al.
Publicado: (2023)

Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker
por: Zhang, Wenqing, et al.
Publicado: (2023)

A comprehensive pan-cancer analysis identifies a novel glycolysis score and its hub genes as prognostic and immunological biomarkers
por: Zheng, Danxi, et al.
Publicado: (2023)

Prognostic and immunological characteristics of CDK1 in lung adenocarcinoma: A systematic analysis
por: Du, Qingwu, et al.
Publicado: (2023)

A systematic pan-cancer analysis identifies TRIM28 as an immunological and prognostic predictor and involved in immunotherapy resistance
por: Shang, Zhi, et al.
Publicado: (2023)

Prognostic and immunological role of Fam20C in pan-cancer
por: Liu, Xinpeng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_69v8e38gu71rmqebuetdtf0eg0